Experimental Oncology
  • Home
    • About edition
  • New issue
  • Archive
  • Author
  • Information for authors
  • Publications requirements
  • New website
  • Actual information
  • Book review
  • Brief report
  • Case reports
  • Clinical experience
  • Digest
  • Editorial
  • Exchange of experience
  • Experimental research
  • History of oncology
  • Information
  • International experience
  • Lectures
  • Materials of scientific conferences
  • Official information
  • Opinion
  • Original investigations
  • Review
  • Supplements
    Часопис online
    All news

    Ключевое слово :   doxorubicin

    THE COMBINATION OF LASER IRRADIATION AND DOXORUBICIN AS A FACTOR OF TUMOR CELL APOPTOSIS INDUCTION
    THE COMBINATION OF LASER IRRADIATION AND DOXORUBICIN AS A FACTOR OF TUMOR CELL APOPTOSIS INDUCTION
    Authors:Konovalenko S.V. Zadvornyy T.V. №24 3 2022 19
    DETERMINATION OF EFFECTS AND OPTIMIZATION OF PHOTOBIOMODULATION AND PHOTODYNAMIC THERAPY PARAMETERS FOR PROSTATE AND BREAST CANCER CELL LINES OF DIFFERENT MALIGNANCY GRADE
    DETERMINATION OF EFFECTS AND OPTIMIZATION OF PHOTOBIOMODULATION AND PHOTODYNAMIC THERAPY PARAMETERS FOR PROSTATE AND BREAST CANCER CELL LINES OF DIFFERENT MALIGNANCY GRADE
    Authors:Lykhova O.O. Konovalenko S.V. Chepurna O.M. №23 4 2021 33
    PRECLINICAL INVESTIGATION OF THE INFLUENCE OF B. SUBTILIS IMV B-7724 LECTIN ON THE DYNAMICS OF MACROPHAGES FUNCTIONAL ACTIVITY AFTER TRANSPLANTATION OF CHEMOSENSITIVE OR CHEMORESISTANT EXPERIMENTAL TUMORS
    PRECLINICAL INVESTIGATION OF THE INFLUENCE OF B. SUBTILIS IMV B-7724 LECTIN ON THE DYNAMICS OF MACROPHAGES FUNCTIONAL ACTIVITY AFTER TRANSPLANTATION OF CHEMOSENSITIVE OR CHEMORESISTANT EXPERIMENTAL TUMORS
    Authors:Chumak A.V. Fedosova N.І. Cheremshenko N.L. Karaman О.М. ... №23 1-2 2021 24
    USE OF MACHANOCHEMICALLY ACTIVATED CHARGED NANOPARTICLES OF DOXORUBICIN AS A FACTOR LIMITING COMPLICATIONS IN POLYCHEMOTHERAPY OF PATIENTS WITH MALIGNANT LYMPHOMAS
    USE OF MACHANOCHEMICALLY ACTIVATED CHARGED NANOPARTICLES OF DOXORUBICIN AS A FACTOR LIMITING COMPLICATIONS IN POLYCHEMOTHERAPY OF PATIENTS WITH MALIGNANT LYMPHOMAS
    Authors:S.A. Sivkovich V.E Orel N.N. Dzyatkovskaya 2019-05-07 5
    APPLYING OF LIPOSOMAL FORM OF DOXORUBICIN IN PATIENTS WITH DOXORUBICIN-RESISTANT BREAST CANCER
    APPLYING OF LIPOSOMAL FORM OF DOXORUBICIN IN PATIENTS WITH DOXORUBICIN-RESISTANT BREAST CANCER
    Authors:Pivnuk V.M. Tymovska Yu.O. Ponomareva O.V. Kulyk G.I. ... №9 2 2007 2
    USE OF MACHANOCHEMICALLY ACTIVATED CHARGED NANOPARTICLES OF DOXORUBICIN AS A FACTOR LIMITING COMPLICATIONS IN POLYCHEMOTHERAPY OF PATIENTS WITH MALIGNANT LYMPHOMAS
    USE OF MACHANOCHEMICALLY ACTIVATED CHARGED NANOPARTICLES OF DOXORUBICIN AS A FACTOR LIMITING COMPLICATIONS IN POLYCHEMOTHERAPY OF PATIENTS WITH MALIGNANT LYMPHOMAS
    Authors:Sivkovich S.A. Orel V.E Dzyatkovskaya N.N. №9 3 2007 1
    TREATMENT OF CHILDREN WITH OSTEOSARCOMA
    TREATMENT OF CHILDREN WITH OSTEOSARCOMA
    Authors:Kobys V.L. Klymnyuk G.I. Tarasova T.O. Ryepina N.V. ... №8 4 2006 4
    Анонси та пресрелізи
    Всі новини
    Читаються за рейтингом

    INFLUENCE OF COVID19 AND VACCINATION AGAINST SARS-COV-2 ON...

    THE ROLE OF EUROPEAN TARGETED PROJECT CCI4EU IN...

    DIFFERENTIATED APPROACH TO THE TREATMENT OF PATIENTS WITH...

    IDENTIFICATION OF TARGET GENES FOR NOVEL METABOLIC STRATEGIES...

    EFFECT OF B. ANIMALIS AND B. SUBTILIS ІМВ...

    Publishing House “Akademperiodyka” Apteka online Компендиум — справочник лекарств №1 Chasopys online Oncology

    Publishing House “Akademperiodyka”
    Editorial office and publisher: 01004, Kyiv, 4 Tereschenkivska st.
    Tel.: +380 (44) 234-75-54

    Specialized medical online edition for doctors,
    pharmacists, students of medical and pharmaceutical universities
    pharmaceutical universities. Disclaimer

    Apteka online Компендиум Chasopys online Oncology